Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting
24/02/2026 12:11
Feb 24 (Reuters) - Aptose Biosciences Inc APS.TO: APTOSE BIOSCIENCES ANNOUNCES AMENDMENT TO ARRANGEMENT AGREEMENT AND DETAILS OF POSTPONED SPECIAL MEETING OF SHAREHOLDERS APTOSE BIOSCIENCES INC - TO CONTINUE UNDER ALBERTA BUSINESS CORPORATIONS ACT APTOSE BIOSCIENCES INC - TO BE ACQUIRED BY HS NORTH AMERICA LTD, A UNIT OF HANMI PHARMACEUTICAL CO. LTD APTOSE BIOSCIENCES INC - ENTERS $11.1 MILLION FACILITY AGREEMENT WITH HANMI Source text: ID:nGNX149Fr6 Further company coverage: APS.TO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting